» Articles » PMID: 22264170

Pinophilins A and B, Inhibitors of Mammalian A-, B-, and Y-family DNA Polymerases and Human Cancer Cell Proliferation

Overview
Journal J Nat Prod
Date 2012 Jan 24
PMID 22264170
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Pinophilins A (1) and B (2), new hydrogenated azaphilones, and Sch 725680 (3) were isolated from cultures of a fungus (Penicillium pinophilum Hedgcok) derived from a seaweed, and their structures were determined using spectroscopic analyses. These compounds selectively inhibited the activities of mammalian DNA polymerases (pols), A (pol γ), B (pols α, δ, and ε), and Y (pols η, ι, and κ) families, but did not influence the activities of the four X-family pols (pols β, λ, μ, and terminal deoxynucleotidyl transferase). Compound 1 was the strongest inhibitor, with IC₅₀ values of 48.6 to 55.6 μM. Kinetic analysis showed that compound 1 is a noncompetitive inhibitor of both pol α and κ activities with the DNA template-primer substrate, and a competitive inhibitor with the nucleotide substrate. In contrast, compounds 1-3 showed no effect on the activities of plant and prokaryotic pols or any other DNA metabolic enzymes tested. The compounds suppressed cell proliferation and growth in five human cancer cell lines, but had no effect on the viability of normal human cell lines.

Citing Articles

Enzyme Inhibitors from Gorgonians and Soft Corals.

Cordova-Isaza A, Jimenez-Marmol S, Guerra Y, Salas-Sarduy E Mar Drugs. 2023; 21(2).

PMID: 36827145 PMC: 9963996. DOI: 10.3390/md21020104.


Bioactive Microbial Metabolites in Cancer Therapeutics: Mining, Repurposing, and Their Molecular Targets.

Pattnaik S, Imchen M, Kumavath R, Prasad R, Busi S Curr Microbiol. 2022; 79(10):300.

PMID: 36002695 DOI: 10.1007/s00284-022-02990-7.


DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target.

Ler A, Carty M Front Oncol. 2022; 11:822500.

PMID: 35198436 PMC: 8859465. DOI: 10.3389/fonc.2021.822500.


Genome mining combined metabolic shunting and OSMAC strategy of an endophytic fungus leads to the production of diverse natural products.

Wei Q, Bai J, Yan D, Bao X, Li W, Liu B Acta Pharm Sin B. 2021; 11(2):572-587.

PMID: 33643832 PMC: 7893140. DOI: 10.1016/j.apsb.2020.07.020.


Antibiotics from Extremophilic Micromycetes.

Baranova A, Alferova V, Korshun V, Tyurin A Russ J Bioorg Chem. 2021; 46(6):903-971.

PMID: 33390684 PMC: 7768999. DOI: 10.1134/S1068162020060023.